Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities

Clin Transl Sci. 2016 Apr;9(2):89-104. doi: 10.1111/cts.12391. Epub 2016 Mar 30.

Authors

K M Morrissey¹, T M Yuraszeck², C-C Li¹, Y Zhang², S Kasichayanula²

Affiliations

¹ Department of Clinical Pharmacology, Genentech Inc, South San Francisco, California, USA.
² Clinical Pharmacology, Modeling and Simulation, , Amgen Inc, Thousand Oaks, California, USA.

No abstract available

Publication types

Review

MeSH terms

Clinical Trials as Topic
Drug Approval
Humans
Immunotherapy* / adverse effects
Medical Oncology*
Neoplasms / immunology
Neoplasms / therapy
Social Control, Formal